Doma Perpetual Capital Management LLC increased its position in Afya Limited (NASDAQ:AFYA - Free Report) by 4.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 592,220 shares of the company's stock after buying an additional 25,111 shares during the period. Afya accounts for 4.2% of Doma Perpetual Capital Management LLC's portfolio, making the stock its 8th largest holding. Doma Perpetual Capital Management LLC owned 0.63% of Afya worth $10,619,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio boosted its position in Afya by 40.0% during the fourth quarter. Public Employees Retirement System of Ohio now owns 2,800 shares of the company's stock worth $44,000 after purchasing an additional 800 shares during the period. Tower Research Capital LLC TRC raised its stake in shares of Afya by 1,099.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company's stock valued at $64,000 after purchasing an additional 3,695 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Afya by 2,115.9% during the fourth quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock worth $106,000 after acquiring an additional 6,369 shares in the last quarter. Aquatic Capital Management LLC raised its stake in Afya by 47.6% during the fourth quarter. Aquatic Capital Management LLC now owns 9,300 shares of the company's stock worth $148,000 after acquiring an additional 3,000 shares in the last quarter. Finally, Nuveen LLC acquired a new position in Afya during the first quarter worth $226,000. Institutional investors own 88.02% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have recently commented on AFYA shares. Wall Street Zen upgraded Afya from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Morgan Stanley set a $17.50 target price on Afya and gave the stock an "overweight" rating in a report on Wednesday, August 6th. UBS Group restated a "neutral" rating and set a $19.50 target price (up previously from $17.50) on shares of Afya in a report on Thursday, June 12th. Citigroup raised Afya from a "sell" rating to a "neutral" rating and dropped their price target for the stock from $16.00 to $14.00 in a research report on Tuesday, July 29th. Finally, Zacks Research raised Afya to a "hold" rating in a research report on Friday, August 8th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Afya has a consensus rating of "Hold" and an average target price of $17.50.
View Our Latest Research Report on Afya
Afya Stock Up 0.2%
Afya stock traded up $0.03 during midday trading on Wednesday, reaching $15.06. The stock had a trading volume of 89,718 shares, compared to its average volume of 109,990. The firm's fifty day simple moving average is $15.43 and its 200-day simple moving average is $17.10. Afya Limited has a 1-year low of $13.47 and a 1-year high of $19.90. The stock has a market capitalization of $1.41 billion, a P/E ratio of 11.41, a price-to-earnings-growth ratio of 0.54 and a beta of 0.56. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.94 and a current ratio of 0.94.
Afya Company Profile
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Read More

Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.